The Senate voted nearly unanimously this week to advance their Opioids response legislation, which will now need to be merged with the House-passed version. NAHU has closely followed this as the House-version would increasingly shift costs for several more months of coverage for end stage renal disease onto employers before Medicare becomes the primary payer. On this week’s episode, NAHU’s Chris Hartmann and John Greene explain how employer plans could be impacted as Congress seeks to send the legislative package to President Trump in the coming weeks. John and Chris also review the current status of the House’s employer-related ACA reforms after the House recessed early last week, delaying indefinitely a vote on H.R. 3798 that would have restored the 40-hour workweek and further delayed the Cadillac/excise Tax. They also look at the growing interest in advancing surprise medical billing legislation at the federal level, and the Trump Administration’s efforts to bring transparency to prescription drug prices on the 15th anniversary of Medicare Part D.
Do you have a topic you’d like us to cover or a question you would like us to address in an upcoming podcast? If so, send us an email here.